540 
Pharmaceutical  M eetings. 
(Am.  Jour.  Pharm. 
1  November,  1911. 
consisting  of  Howard  B.  French,  W.  L.  Cliffe  and  Professor  Joseph 
P.  Remington  was  appointed  to  consider  the  matter. 
The  Committee  on  Commencement  reported  all  the  exercises 
attending  Commencement  had  passed  of¥  nicely,  and  it  was  moved 
that  a  resolution  of  thanks  be  tendered  the  Speaker  and  Minister 
officiating.  So  ordered.  The  Committee  reported  that  the  Com- 
mencement in  1912  would  take  place  on  Thursday,  May  23rd,  at 
the  Academy  of  Music,  which  would  be  engaged  for  the  occasion. 
The  Treasurer  was  authorized  to  pay  the  salary  lists  during 
the  summer  of  the  Board,  and  such  other  bills  as  were  approved 
by  the  Committee  on  Accounts  and  Audits. 
(Signed)  C.  A.  Weidemann, 
Secretary. 
PHARMACEUTICAL  MEETINGS. 
The  pharmaceutical  meetings  of  the  Philadelphia  College  of 
Pharmacy  have  been  held  for  many  years  on  the  third  Tuesday  of 
the  month  from  October  to  May.  The  section  in  the  article  of  the 
by-laws  of  the  college,  relating  to  the  date  of  these  meetings,  has 
been  changed  (see  account  of  the  September  meeting  of  the  college 
given  elsewhere  in  this  issue),  leaving  it  optional  with  the  committee 
to  fix  the  date  of  each  meeting.  The  first  meeting  was  held  on 
Monday,  October  i6th,  at  3  p.m.,  Mr.  William  L.  Clifife  acting  as 
chairman. 
Mr.  George  M.  Beringer  presented  a  communication  upon  "  The 
Pharmacists'  Plea  for  a  Rational  Pharmacopoeia  "  and  Mr.  Otto 
Raubenheimer,  of  Brooklyn,  spoke  upon  "  The  List  of  Proposed 
Deletions  "  of  the  new  U.  S.  Pharmacopcjeia.  Both  speakers  re- 
ferred to  a  number  of  substances  which  they  considered  should 
be  included  in  the  new  Pharmacopoeia  as  in  some  cases  the  prep- 
arations of  the  drugs  were  retained.  Professor  Remington,  chair- 
man of  the  Committee  of  Revision  of  the  U.  S.  Pharmacopoeia, 
stated  that  in  some  instances  the  omissions  were  due  to  mere  over- 
sight and  that  nearly  all  of  the  substances  referred  to  were  being 
further  considered  either  with  regard  to  their  inclusion  or  deletion 
in  the  forthcoming  Pharmacopoeia.  He  also  emphasized  the  impor- 
tance of  abiding  by  the  majority  vote  as  it  is  impracticable  to  do 
otherwise. 
The  discussion  was  also  participated  in  by  Dr.  Lowe,  Mr.  H. 
